Global HER2 Targeted Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 115 pages | ID: G1CBAB313DAEEN
LP Information

Abstracts

According to this study, the global HER2 Targeted Therapy market size will reach US$ million by 2031.

United States market for HER2 Targeted Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for HER2 Targeted Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for HER2 Targeted Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key HER2 Targeted Therapy players cover GlaxoSmithKline, Bayer, Abbott, AbbVie, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “HER2 Targeted Therapy Industry Forecast” looks at past sales and reviews total world HER2 Targeted Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected HER2 Targeted Therapy sales for 2025 through 2031. With HER2 Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Targeted Therapy industry.

This Insight Report provides a comprehensive analysis of the global HER2 Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HER2 Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER2 Targeted Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Targeted Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Targeted Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Targeted Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monotherapy
• Combination Therapy
• Others

Segmentation by Application:

• Breast Cancer
• Stomach Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Bayer
• Abbott
• AbbVie
• Pfizer
• Sanofi
• Agilent
• Glenmark Pharmaceuticals
• Merck
• Roche
• Novartis
• Astra Zeneca
• Daiichi Sankyo

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HER2 Targeted Therapy Market Size (2020-2031)
  2.1.2 HER2 Targeted Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for HER2 Targeted Therapy by Country/Region (2020, 2024 & 2031)
2.2 HER2 Targeted Therapy Segment by Type
  2.2.1 Monotherapy
  2.2.2 Combination Therapy
  2.2.3 Others
2.3 HER2 Targeted Therapy Market Size by Type
  2.3.1 HER2 Targeted Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global HER2 Targeted Therapy Market Size Market Share by Type (2020-2025)
2.4 HER2 Targeted Therapy Segment by Application
  2.4.1 Breast Cancer
  2.4.2 Stomach Cancer
  2.4.3 Head and Neck Cancer
  2.4.4 Lung Cancer
  2.4.5 Ovarian Cancer
  2.4.6 Others
2.5 HER2 Targeted Therapy Market Size by Application
  2.5.1 HER2 Targeted Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global HER2 Targeted Therapy Market Size Market Share by Application (2020-2025)

3 HER2 TARGETED THERAPY MARKET SIZE BY PLAYER

3.1 HER2 Targeted Therapy Market Size Market Share by Player
  3.1.1 Global HER2 Targeted Therapy Revenue by Player (2020-2025)
  3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Player (2020-2025)
3.2 Global HER2 Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HER2 TARGETED THERAPY BY REGION

4.1 HER2 Targeted Therapy Market Size by Region (2020-2025)
4.2 Global HER2 Targeted Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas HER2 Targeted Therapy Market Size Growth (2020-2025)
4.4 APAC HER2 Targeted Therapy Market Size Growth (2020-2025)
4.5 Europe HER2 Targeted Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa HER2 Targeted Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas HER2 Targeted Therapy Market Size by Country (2020-2025)
5.2 Americas HER2 Targeted Therapy Market Size by Type (2020-2025)
5.3 Americas HER2 Targeted Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HER2 Targeted Therapy Market Size by Region (2020-2025)
6.2 APAC HER2 Targeted Therapy Market Size by Type (2020-2025)
6.3 APAC HER2 Targeted Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe HER2 Targeted Therapy Market Size by Country (2020-2025)
7.2 Europe HER2 Targeted Therapy Market Size by Type (2020-2025)
7.3 Europe HER2 Targeted Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HER2 Targeted Therapy by Region (2020-2025)
8.2 Middle East & Africa HER2 Targeted Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa HER2 Targeted Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HER2 TARGETED THERAPY MARKET FORECAST

10.1 Global HER2 Targeted Therapy Forecast by Region (2026-2031)
  10.1.1 Global HER2 Targeted Therapy Forecast by Region (2026-2031)
  10.1.2 Americas HER2 Targeted Therapy Forecast
  10.1.3 APAC HER2 Targeted Therapy Forecast
  10.1.4 Europe HER2 Targeted Therapy Forecast
  10.1.5 Middle East & Africa HER2 Targeted Therapy Forecast
10.2 Americas HER2 Targeted Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market HER2 Targeted Therapy Forecast
  10.2.2 Canada Market HER2 Targeted Therapy Forecast
  10.2.3 Mexico Market HER2 Targeted Therapy Forecast
  10.2.4 Brazil Market HER2 Targeted Therapy Forecast
10.3 APAC HER2 Targeted Therapy Forecast by Region (2026-2031)
  10.3.1 China HER2 Targeted Therapy Market Forecast
  10.3.2 Japan Market HER2 Targeted Therapy Forecast
  10.3.3 Korea Market HER2 Targeted Therapy Forecast
  10.3.4 Southeast Asia Market HER2 Targeted Therapy Forecast
  10.3.5 India Market HER2 Targeted Therapy Forecast
  10.3.6 Australia Market HER2 Targeted Therapy Forecast
10.4 Europe HER2 Targeted Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market HER2 Targeted Therapy Forecast
  10.4.2 France Market HER2 Targeted Therapy Forecast
  10.4.3 UK Market HER2 Targeted Therapy Forecast
  10.4.4 Italy Market HER2 Targeted Therapy Forecast
  10.4.5 Russia Market HER2 Targeted Therapy Forecast
10.5 Middle East & Africa HER2 Targeted Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market HER2 Targeted Therapy Forecast
  10.5.2 South Africa Market HER2 Targeted Therapy Forecast
  10.5.3 Israel Market HER2 Targeted Therapy Forecast
  10.5.4 Turkey Market HER2 Targeted Therapy Forecast
10.6 Global HER2 Targeted Therapy Forecast by Type (2026-2031)
10.7 Global HER2 Targeted Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market HER2 Targeted Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 GlaxoSmithKline Company Information
  11.1.2 GlaxoSmithKline HER2 Targeted Therapy Product Offered
  11.1.3 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GlaxoSmithKline Main Business Overview
  11.1.5 GlaxoSmithKline Latest Developments
11.2 Bayer
  11.2.1 Bayer Company Information
  11.2.2 Bayer HER2 Targeted Therapy Product Offered
  11.2.3 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer Main Business Overview
  11.2.5 Bayer Latest Developments
11.3 Abbott
  11.3.1 Abbott Company Information
  11.3.2 Abbott HER2 Targeted Therapy Product Offered
  11.3.3 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Abbott Main Business Overview
  11.3.5 Abbott Latest Developments
11.4 AbbVie
  11.4.1 AbbVie Company Information
  11.4.2 AbbVie HER2 Targeted Therapy Product Offered
  11.4.3 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AbbVie Main Business Overview
  11.4.5 AbbVie Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer HER2 Targeted Therapy Product Offered
  11.5.3 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments
11.6 Sanofi
  11.6.1 Sanofi Company Information
  11.6.2 Sanofi HER2 Targeted Therapy Product Offered
  11.6.3 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Sanofi Main Business Overview
  11.6.5 Sanofi Latest Developments
11.7 Agilent
  11.7.1 Agilent Company Information
  11.7.2 Agilent HER2 Targeted Therapy Product Offered
  11.7.3 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Agilent Main Business Overview
  11.7.5 Agilent Latest Developments
11.8 Glenmark Pharmaceuticals
  11.8.1 Glenmark Pharmaceuticals Company Information
  11.8.2 Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
  11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Glenmark Pharmaceuticals Main Business Overview
  11.8.5 Glenmark Pharmaceuticals Latest Developments
11.9 Merck
  11.9.1 Merck Company Information
  11.9.2 Merck HER2 Targeted Therapy Product Offered
  11.9.3 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Merck Main Business Overview
  11.9.5 Merck Latest Developments
11.10 Roche
  11.10.1 Roche Company Information
  11.10.2 Roche HER2 Targeted Therapy Product Offered
  11.10.3 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Roche Main Business Overview
  11.10.5 Roche Latest Developments
11.11 Novartis
  11.11.1 Novartis Company Information
  11.11.2 Novartis HER2 Targeted Therapy Product Offered
  11.11.3 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Novartis Main Business Overview
  11.11.5 Novartis Latest Developments
11.12 Astra Zeneca
  11.12.1 Astra Zeneca Company Information
  11.12.2 Astra Zeneca HER2 Targeted Therapy Product Offered
  11.12.3 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Astra Zeneca Main Business Overview
  11.12.5 Astra Zeneca Latest Developments
11.13 Daiichi Sankyo
  11.13.1 Daiichi Sankyo Company Information
  11.13.2 Daiichi Sankyo HER2 Targeted Therapy Product Offered
  11.13.3 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Daiichi Sankyo Main Business Overview
  11.13.5 Daiichi Sankyo Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. HER2 Targeted Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. HER2 Targeted Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monotherapy
Table 4. Major Players of Combination Therapy
Table 5. Major Players of Others
Table 6. HER2 Targeted Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global HER2 Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 8. Global HER2 Targeted Therapy Market Size Market Share by Type (2020-2025)
Table 9. HER2 Targeted Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global HER2 Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global HER2 Targeted Therapy Market Size Market Share by Application (2020-2025)
Table 12. Global HER2 Targeted Therapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global HER2 Targeted Therapy Revenue Market Share by Player (2020-2025)
Table 14. HER2 Targeted Therapy Key Players Head office and Products Offered
Table 15. HER2 Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global HER2 Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global HER2 Targeted Therapy Market Size Market Share by Region (2020-2025)
Table 20. Global HER2 Targeted Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global HER2 Targeted Therapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas HER2 Targeted Therapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas HER2 Targeted Therapy Market Size Market Share by Country (2020-2025)
Table 24. Americas HER2 Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas HER2 Targeted Therapy Market Size Market Share by Type (2020-2025)
Table 26. Americas HER2 Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas HER2 Targeted Therapy Market Size Market Share by Application (2020-2025)
Table 28. APAC HER2 Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC HER2 Targeted Therapy Market Size Market Share by Region (2020-2025)
Table 30. APAC HER2 Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC HER2 Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe HER2 Targeted Therapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe HER2 Targeted Therapy Market Size Market Share by Country (2020-2025)
Table 34. Europe HER2 Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe HER2 Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa HER2 Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa HER2 Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa HER2 Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of HER2 Targeted Therapy
Table 40. Key Market Challenges & Risks of HER2 Targeted Therapy
Table 41. Key Industry Trends of HER2 Targeted Therapy
Table 42. Global HER2 Targeted Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global HER2 Targeted Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global HER2 Targeted Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global HER2 Targeted Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. GlaxoSmithKline Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 47. GlaxoSmithKline HER2 Targeted Therapy Product Offered
Table 48. GlaxoSmithKline HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. GlaxoSmithKline Main Business
Table 50. GlaxoSmithKline Latest Developments
Table 51. Bayer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 52. Bayer HER2 Targeted Therapy Product Offered
Table 53. Bayer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Bayer Main Business
Table 55. Bayer Latest Developments
Table 56. Abbott Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 57. Abbott HER2 Targeted Therapy Product Offered
Table 58. Abbott HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Abbott Main Business
Table 60. Abbott Latest Developments
Table 61. AbbVie Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 62. AbbVie HER2 Targeted Therapy Product Offered
Table 63. AbbVie HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. AbbVie Main Business
Table 65. AbbVie Latest Developments
Table 66. Pfizer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 67. Pfizer HER2 Targeted Therapy Product Offered
Table 68. Pfizer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Sanofi Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 72. Sanofi HER2 Targeted Therapy Product Offered
Table 73. Sanofi HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Sanofi Main Business
Table 75. Sanofi Latest Developments
Table 76. Agilent Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 77. Agilent HER2 Targeted Therapy Product Offered
Table 78. Agilent HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Agilent Main Business
Table 80. Agilent Latest Developments
Table 81. Glenmark Pharmaceuticals Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 82. Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
Table 83. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Glenmark Pharmaceuticals Main Business
Table 85. Glenmark Pharmaceuticals Latest Developments
Table 86. Merck Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 87. Merck HER2 Targeted Therapy Product Offered
Table 88. Merck HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Merck Main Business
Table 90. Merck Latest Developments
Table 91. Roche Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 92. Roche HER2 Targeted Therapy Product Offered
Table 93. Roche HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Roche Main Business
Table 95. Roche Latest Developments
Table 96. Novartis Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 97. Novartis HER2 Targeted Therapy Product Offered
Table 98. Novartis HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Novartis Main Business
Table 100. Novartis Latest Developments
Table 101. Astra Zeneca Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 102. Astra Zeneca HER2 Targeted Therapy Product Offered
Table 103. Astra Zeneca HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Astra Zeneca Main Business
Table 105. Astra Zeneca Latest Developments
Table 106. Daiichi Sankyo Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 107. Daiichi Sankyo HER2 Targeted Therapy Product Offered
Table 108. Daiichi Sankyo HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Daiichi Sankyo Main Business
Table 110. Daiichi Sankyo Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. HER2 Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER2 Targeted Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. HER2 Targeted Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. HER2 Targeted Therapy Sales Market Share by Country/Region (2024)
Figure 8. HER2 Targeted Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global HER2 Targeted Therapy Market Size Market Share by Type in 2024
Figure 10. HER2 Targeted Therapy in Breast Cancer
Figure 11. Global HER2 Targeted Therapy Market: Breast Cancer (2020-2025) & ($ millions)
Figure 12. HER2 Targeted Therapy in Stomach Cancer
Figure 13. Global HER2 Targeted Therapy Market: Stomach Cancer (2020-2025) & ($ millions)
Figure 14. HER2 Targeted Therapy in Head and Neck Cancer
Figure 15. Global HER2 Targeted Therapy Market: Head and Neck Cancer (2020-2025) & ($ millions)
Figure 16. HER2 Targeted Therapy in Lung Cancer
Figure 17. Global HER2 Targeted Therapy Market: Lung Cancer (2020-2025) & ($ millions)
Figure 18. HER2 Targeted Therapy in Ovarian Cancer
Figure 19. Global HER2 Targeted Therapy Market: Ovarian Cancer (2020-2025) & ($ millions)
Figure 20. HER2 Targeted Therapy in Others
Figure 21. Global HER2 Targeted Therapy Market: Others (2020-2025) & ($ millions)
Figure 22. Global HER2 Targeted Therapy Market Size Market Share by Application in 2024
Figure 23. Global HER2 Targeted Therapy Revenue Market Share by Player in 2024
Figure 24. Global HER2 Targeted Therapy Market Size Market Share by Region (2020-2025)
Figure 25. Americas HER2 Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 26. APAC HER2 Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 27. Europe HER2 Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa HER2 Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 29. Americas HER2 Targeted Therapy Value Market Share by Country in 2024
Figure 30. United States HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC HER2 Targeted Therapy Market Size Market Share by Region in 2024
Figure 35. APAC HER2 Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 36. APAC HER2 Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 37. China HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. India HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe HER2 Targeted Therapy Market Size Market Share by Country in 2024
Figure 44. Europe HER2 Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 45. Europe HER2 Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 46. Germany HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. France HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. UK HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 54. Egypt HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries HER2 Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 60. APAC HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 61. Europe HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 63. United States HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 64. Canada HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 65. Mexico HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 66. Brazil HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 67. China HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 68. Japan HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 69. Korea HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 71. India HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 72. Australia HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 73. Germany HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 74. France HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 75. UK HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 76. Italy HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 77. Russia HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 78. Egypt HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 79. South Africa HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 80. Israel HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 81. Turkey HER2 Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 82. Global HER2 Targeted Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global HER2 Targeted Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries HER2 Targeted Therapy Market Size 2026-2031 ($ millions)